佰仁医疗收盘下跌1.26%，滚动市盈率82.11倍，总市值140.01亿元

Group 1 - The core viewpoint of the article highlights that Baijun Medical's stock closed at 101.9 yuan, down 1.26%, with a rolling PE ratio of 82.11 times and a total market value of 14 billion yuan [1] - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, placing Baijun Medical at the 103rd position in the industry ranking [1] - As of March 31, 2025, Baijun Medical has 3,099 shareholders, an increase of 288 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Baijun Medical's main business includes the research, production, sales, and service of medical devices, with key products such as biological patches for cardiac and thoracic surgery, artificial heart valves, and other surgical implant products [1] - In the latest quarterly report for Q1 2025, the company achieved a revenue of 100 million yuan, a year-on-year increase of 31.30%, and a net profit of 32.5 million yuan, reflecting a significant year-on-year growth of 290.69%, with a gross profit margin of 85.72% [1]